Reviewer: WANG Shu-sen, Literature Co-worker: ZHANG Liu-lu. PALOMA-3 Trial: Fulvestrant Plus Palbociclib Improve Progression-Free Survival of Advanced Breast Cancer Patients with Endocrine Treatment Failure[J]. Journal of Evidence-Based Medicine, 2016, 16(3): 152-154. DOI: 10.12019/j.issn.1671-5144.2016.03.009
|
Citation:
|
Reviewer: WANG Shu-sen, Literature Co-worker: ZHANG Liu-lu. PALOMA-3 Trial: Fulvestrant Plus Palbociclib Improve Progression-Free Survival of Advanced Breast Cancer Patients with Endocrine Treatment Failure[J]. Journal of Evidence-Based Medicine, 2016, 16(3): 152-154. DOI: 10.12019/j.issn.1671-5144.2016.03.009
|
Reviewer: WANG Shu-sen, Literature Co-worker: ZHANG Liu-lu. PALOMA-3 Trial: Fulvestrant Plus Palbociclib Improve Progression-Free Survival of Advanced Breast Cancer Patients with Endocrine Treatment Failure[J]. Journal of Evidence-Based Medicine, 2016, 16(3): 152-154. DOI: 10.12019/j.issn.1671-5144.2016.03.009
|
Citation:
|
Reviewer: WANG Shu-sen, Literature Co-worker: ZHANG Liu-lu. PALOMA-3 Trial: Fulvestrant Plus Palbociclib Improve Progression-Free Survival of Advanced Breast Cancer Patients with Endocrine Treatment Failure[J]. Journal of Evidence-Based Medicine, 2016, 16(3): 152-154. DOI: 10.12019/j.issn.1671-5144.2016.03.009
|
DownLoad: